Tepoditamab Biosimilar – Anti-CD3E, CLEC12A mAb – Research Grade

(1 customer review)
Reference:
Size

,

Brand

Product type

Clonality

Expression system

Description of Tepoditamab Biosimilar - Anti-CD3E/CLEC12A mAb - Research Grade

Description of Tepoditamab Biosimilar - Anti-CD3E/CLEC12A mAb - Research Grade

Product nameTepoditamab Biosimilar - Anti-CD3E, CLEC12A mAb - Research Grade
SourceCAS 2044679-53-8
SpeciesHomo sapiens
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsMCLA-117, PB9122
ReferencePX-TA1516
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody
SourceCAS 2044679-53-8
Product nameTepoditamab Biosimilar - Anti-CD3E, CLEC12A mAb - Research Grade
SourceCAS 2044679-53-8
SpeciesHomo sapiens
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsMCLA-117, PB9122
ReferencePX-TA1516
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody
SourceCAS 2044679-53-8

1 review for Tepoditamab Biosimilar – Anti-CD3E, CLEC12A mAb – Research Grade

  1. Vele

    Great product!

Add a review

Your email address will not be published.


Clear
OK

Please select the country of delivery so that we can send you the quotation including shipping costs.

Thank you for your request! You will receive your quotation per e-mail in a few seconds.

If you did not receive your quotation, please check your spam folder.

Contact us to order

+33 (0)3 90 20 54 70

Write us

Categories: